I G Kovalenko - JoVE Visualize

Showing results (21-30 of 51) with videos related to

Pageof 6

Sort By:

Voprosy Onkologii|June 6, 2003

[Hormonal-metabolic status of cancer patients with late-onset menopause]D M Bershteĭn, A E Chernobrovkina, V B Gamaiunova, et al.

Advances in Gerontology = Uspekhi Gerontologii|October 24, 2008

[The dual (joker) function of glucose: study of its association with aging and glucose metabolism disorders]D A Vasil'ev, T E Poroshina, I G Kovalenko, et al.

Bulletin of Experimental Biology and Medicine|June 13, 2003

Modification of the uterotropic effect produced by estrogens in aging ratsL M Bershtein, E V Tsyrlina, T E Poroshina, et al.

Voprosy Onkologii|March 15, 2011

[Influence of metformin and N-acetylcysteine on hormonal and genotoxic effects of estrogens and glucose in convalescent cancer patients]L M Bershteĭn, D A Vasil'ev, T E Poroshina, et al.

Voprosy Onkologii|January 1, 1996

[Specifics of metabolic disorders in patients with "hormone-associated neoplastic" syndromes]E P Rybin, L M Bershtein, E V Tsyrlina, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1997

Hormone-metabolic status in moderately smoking breast cancer patientsL M Berstein, E V Tsyrlina, V F Semiglazov, et al.

Voprosy Onkologii|December 25, 2007

[Properties of mammary fat in breast cancer patients: topographic, systemic and environmental factors]L M Bershteĭn, A Iu Kovalevskiĭ, T E Poroshina, et al.

Experimental Oncology|April 15, 2006

Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effectsL M Berstein, E V Tsyrlina, T E Poroshina, et al.

Akusherstvo I Ginekologiia|February 1, 1990

[Multifactorial analysis of the effect of metabolic and endocrine factors on cellular immunity in patients with cancer of the uterine body]A S Vishnevskiĭ, E V Bakhidze, Ia V Bokhman, et al.

Voprosy Onkologii|November 17, 2001

[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients]V F Semiglazov, V G Ivanov, V B Gamaiunova, et al.

Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:

Pageof 6

Voprosy Onkologii|June 6, 2003

[Hormonal-metabolic status of cancer patients with late-onset menopause]D M Bershteĭn, A E Chernobrovkina, V B Gamaiunova, et al.

Advances in Gerontology = Uspekhi Gerontologii|October 24, 2008

[The dual (joker) function of glucose: study of its association with aging and glucose metabolism disorders]D A Vasil'ev, T E Poroshina, I G Kovalenko, et al.

Bulletin of Experimental Biology and Medicine|June 13, 2003

Modification of the uterotropic effect produced by estrogens in aging ratsL M Bershtein, E V Tsyrlina, T E Poroshina, et al.

Voprosy Onkologii|March 15, 2011

[Influence of metformin and N-acetylcysteine on hormonal and genotoxic effects of estrogens and glucose in convalescent cancer patients]L M Bershteĭn, D A Vasil'ev, T E Poroshina, et al.

Voprosy Onkologii|January 1, 1996

[Specifics of metabolic disorders in patients with "hormone-associated neoplastic" syndromes]E P Rybin, L M Bershtein, E V Tsyrlina, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1997

Hormone-metabolic status in moderately smoking breast cancer patientsL M Berstein, E V Tsyrlina, V F Semiglazov, et al.

Voprosy Onkologii|December 25, 2007

[Properties of mammary fat in breast cancer patients: topographic, systemic and environmental factors]L M Bershteĭn, A Iu Kovalevskiĭ, T E Poroshina, et al.

Experimental Oncology|April 15, 2006

Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effectsL M Berstein, E V Tsyrlina, T E Poroshina, et al.

Akusherstvo I Ginekologiia|February 1, 1990

[Multifactorial analysis of the effect of metabolic and endocrine factors on cellular immunity in patients with cancer of the uterine body]A S Vishnevskiĭ, E V Bakhidze, Ia V Bokhman, et al.

Voprosy Onkologii|November 17, 2001

[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients]V F Semiglazov, V G Ivanov, V B Gamaiunova, et al.

Pageof 6